#USA #Prytime Medical #pREBOA-PRO #Maternal Care #Boerne, Texas

Prytime Medical's Progress in Maternal Hemorrhage Treatment

Prytime Medical, known as The REBOA Company™, has made significant advancements in the area of maternal care throughout 2024. The innovation centers around the use of the pREBOA-PRO™ catheter, a device designed to combat maternal hemorrhage, particularly in high-risk pregnancies. The company’s dedication to maternal safety is evident in the care stories emerging from mothers like Jessica Barnhart, who battled severe complications during her pregnancy, including a c-section scar ectopic pregnancy and placenta accreta spectrum (PAS).

Jessica’s experience, marked by life-threatening risks, took a positive turn through the intervention of Dr. Robert Cohen at Medical City Dallas. With the pREBOA-PRO catheter, her delivery was supported by advanced techniques, which effectively reduced hemorrhage. Thanks to this intervention, both Jessica and her baby Quin emerged healthy, underscoring the life-saving potential of Prytime's innovative approach. This personal narrative illustrates the importance of technology in navigating the complexities of high-risk pregnancies.

Growing Your Knowledge: The Impact of pREBOA-PRO™ in 2024

In just this year alone, 54 mothers with conditions related to PAS have benefited from improvements made in the obstetric hemorrhage management landscape thanks to the deployment of the pREBOA-PRO catheter. The increase in successful applications signals a broader adoption of this technology among healthcare providers tasked with managing obstetric emergencies. Dr. Cohen pointed out that as the need for innovative treatments for PAS cases rises, the pREBOA-PRO catheter serves as a vital tool, ensuring better maternal outcomes during critical moments.

Expanding Clinical Partnerships and Research Contributions

Prytime Medical has made strides by collaborating with leading hospitals to enhance the management of obstetric hemorrhage and prolonged hemorrhage control protocols. In 2024, new partnerships were formed with two prominent hospitals, paving the way for wider implementation of REBOA techniques in maternal care. These expansions are crucial as the healthcare community collectively seeks methods to mitigate life-threatening risks associated with complex pregnancies.

Furthermore, this dedication to research is evidenced by Prytime’s recent publications analyzing the benefits of prolonged REBOA in managing obstetric hemorrhages. Conducted by Dr. Cohen and his team, these studies not only contribute valuable knowledge but also help solidify the effectiveness of modern medical interventions in saving lives.

Breaking Barriers Through Collaboration

Continuing its commitment to clinical excellence, Prytime Medical facilitated peer-to-peer multicenter discussions throughout 2024. These events gathered clinicians globally to exchange insights about the utility of prolonged REBOA in obstetric cases. This knowledge-sharing offers invaluable perspectives that could be instrumental for providers facing similar challenges worldwide.

Moreover, Prytime Medical sponsored and attended significant obstetric conferences, further enabling discourse on innovative technologies shaping maternal health practices today. These conferences highlight the latest advancements and the continuous evolution of treatment techniques, ensuring that healthcare providers are equipped with the necessary tools and knowledge for better patient outcomes.

Training for a Safer Tomorrow

Prytime also prioritizes hands-on education in its approach to maternal health. Training sessions have been conducted at renowned institutions such as NYU Langone and UF Shands, aiming to arm healthcare teams with the practical skills needed to handle severe hemorrhage cases effectively. Heather Salinas, the Women’s Health Program Manager, emphasizes the urgency of transforming education into practice—aiming for prolonged REBOA to become synonymous with standard obstetric hemorrhage management.

As Prytime Medical's initiatives continue to evolve, the future of maternal care is looking brighter. With a steadfast commitment to patient safety, innovative solutions like the pREBOA-PRO catheter are setting new benchmarks in medical practice, ensuring that no mother has to face the threat of hemorrhage alone.

For permanent access to survivor stories and updates on their initiatives, visit Prytime Medical's official page.